Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melinda Magyari

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2024
All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: NoMelinda Magyari
Danish Medical Journal|March 3, 2016
Gender differences in multiple sclerosis epidemiology and treatment responseMelinda Magyari
The Lancet. Neurology|February 19, 2022
The prognostic value of neurofilament light chain in serumFinn Sellebjerg, Melinda Magyari
Therapeutic Advances in Neurological Disorders|February 17, 2025
The impact of educational attainment on diagnostic and treatment delays in multiple sclerosis: a nationwide cohort study in DenmarkElisabeth Framke, Melinda Magyari,
Ugeskrift for Laeger|December 2, 2010
[Neurosarcoidosis--different manifestations]Melinda Magyari, Jette Frederiksen
Current Opinion in Neurology|March 30, 2019
The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosisMelinda Magyari, Per Soelberg Sorensen
Journal of Neurology, Neurosurgery, and Psychiatry|April 8, 2022
Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosisMelinda Magyari, Nils Koch-Henriksen
Nature Reviews. Neurology|September 29, 2021
Apparent changes in the epidemiology and severity of multiple sclerosisNils Koch-Henriksen, Melinda Magyari
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 16, 2019
Changes in the sex ratio are a good indicator of changes in MS incidence - NoMelinda Magyari, Nils Koch-Henriksen
Frontiers in Neurology|September 25, 2020
Comorbidity in Multiple SclerosisMelinda Magyari, Per Soelberg Sorensen
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2024
All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: NoMelinda Magyari
Danish Medical Journal|March 3, 2016
Gender differences in multiple sclerosis epidemiology and treatment responseMelinda Magyari
The Lancet. Neurology|February 19, 2022
The prognostic value of neurofilament light chain in serumFinn Sellebjerg, Melinda Magyari
Therapeutic Advances in Neurological Disorders|February 17, 2025
The impact of educational attainment on diagnostic and treatment delays in multiple sclerosis: a nationwide cohort study in DenmarkElisabeth Framke, Melinda Magyari,
Ugeskrift for Laeger|December 2, 2010
[Neurosarcoidosis--different manifestations]Melinda Magyari, Jette Frederiksen
Current Opinion in Neurology|March 30, 2019
The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosisMelinda Magyari, Per Soelberg Sorensen
Journal of Neurology, Neurosurgery, and Psychiatry|April 8, 2022
Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosisMelinda Magyari, Nils Koch-Henriksen
Nature Reviews. Neurology|September 29, 2021
Apparent changes in the epidemiology and severity of multiple sclerosisNils Koch-Henriksen, Melinda Magyari
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 16, 2019
Changes in the sex ratio are a good indicator of changes in MS incidence - NoMelinda Magyari, Nils Koch-Henriksen
Frontiers in Neurology|September 25, 2020
Comorbidity in Multiple SclerosisMelinda Magyari, Per Soelberg Sorensen
Pageof 20